466 abstracts found.
- Session type: E-poster/poster Remove Filter
Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC (VISION trial results) — METex14 should be added to UK testing directory
Session type: E-poster/poster
1Heart of England NHS Foundation Trust, 2Royal Marsden NHS Foundation Trust, 3MD Anderson Cancer Center, 4Vall d’Hebron Institute of Oncology, 5Other, 6Fondazione IRCCS Istituto Nazionale dei Tumori, 7Netherlands Cancer Institute, 8Memorial Sloan-Kettering Cancer Center